Kalaris Therapeutics Inc (KLRS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Kalaris Therapeutics Inc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.97x | -18.93x | -112.07x | -584.08x | -108.66x | -340.77x |
| P/B Ratio | 1.63x | 9.82x | -36.59x | -298.77x | 82.95x | 67.35x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 12.23x | 22.63x | 0.85x | 0.69x | 6.69x | 29.39x |
| Quick Ratio | 12.23x | 22.63x | 0.85x | 0.69x | 6.69x | 29.39x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.00x | 0.00x | -0.11x | 0.13x | 0.02x |
YoY = year-over-year change. Source: FMP..